Electromed (ELMD) Net Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,362.00 |
| Dec 31, 2025 | 193.00 |
| Sep 30, 2025 | 596.00 |
| Jun 30, 2025 | -452.00 |
| Mar 31, 2025 | 459.00 |
| Dec 31, 2024 | -176.00 |
| Sep 30, 2024 | -217.00 |
| Jun 30, 2024 | -419.00 |
| Mar 31, 2024 | 600.00 |
| Dec 31, 2023 | 1,248.00 |
| Sep 30, 2023 | -90.00 |
| Jun 30, 2023 | -28.00 |
| Mar 31, 2023 | 341.00 |
| Dec 31, 2022 | 230.00 |
| Sep 30, 2022 | -52.00 |
| Jun 30, 2022 | -1,395.00 |
| Mar 31, 2022 | -335.00 |
| Dec 31, 2021 | 121.00 |
| Sep 30, 2021 | 94.00 |
| Jun 30, 2021 | -84.00 |
| Mar 31, 2021 | -518.00 |
| Dec 31, 2020 | -437.00 |
| Sep 30, 2020 | -13.00 |
| Jun 30, 2020 | 1,228.00 |
| Mar 31, 2020 | 665.00 |
| Dec 31, 2019 | 521.00 |
| Sep 30, 2019 | 431.00 |
| Jun 30, 2019 | 637.00 |
| Mar 31, 2019 | 3,015.00 |
| Dec 31, 2018 | 1,158.00 |
| Sep 30, 2018 | 1,197.00 |
| Jun 30, 2018 | 1,791.00 |
| Mar 31, 2018 | 1,873.00 |
| Dec 31, 2017 | 1,669.00 |
| Sep 30, 2017 | 305.00 |
| Jun 30, 2017 | 1,691.00 |
| Mar 31, 2017 | 772.00 |
| Dec 31, 2016 | 645.00 |
| Sep 30, 2016 | -112.00 |
| Jun 30, 2016 | 175.00 |
| Mar 31, 2016 | -164.00 |
| Dec 31, 2015 | 1,082.00 |
| Sep 30, 2015 | 413.00 |